Cassava sciences to present at the jefferies biotech cns/neuro summit in ny

Austin, texas, oct. 05, 2023 (globe newswire) -- cassava sciences, inc. (nasdaq: sava), a biotechnology company committed to the treatment of alzheimer's disease dementia, today announced that remi barbier, president & chief executive officer, is invited to present at the jefferies biotech cns/neuro summit in new york on wednesday, october 11, 2023 at 10:30am et. a live webcast and archived replay will also be available.
SAVA Ratings Summary
SAVA Quant Ranking